Belfast, Ireland

Neil McFerran

This inventor holds 1 USPTO granted patent. Top assignee: The Queen's University of Belfast. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil McFerran. Retrieved from https://idiyas.com/inventor/neil-mcferran

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neil McFerran: Innovator in Peptide Research

Introduction

Neil McFerran is a notable inventor based in Belfast, Ireland. He has made significant contributions to the field of peptide research, particularly in the area of epidermal growth factors. His work has implications for various applications in biomedical research and therapeutics.

Latest Patents

Neil McFerran holds a patent titled "Peptide fragments of murine epidermal growth factor as laminin receptor targets." This patent describes a peptide factor and its analogs, which are modified to protect them from proteolytic degradation. The peptide binds to laminin receptors, showcasing its potential in medical applications.

Career Highlights

Neil is affiliated with The Queen's University of Belfast, where he conducts his research. His academic background and innovative work have positioned him as a key figure in his field. He has been instrumental in advancing the understanding of peptide interactions and their potential uses.

Collaborations

Neil has collaborated with notable colleagues, including John Nelson and Brian Walker. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Neil McFerran's contributions to peptide research and his innovative patent highlight his role as a significant inventor in the scientific community. His work continues to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…